VCNX Vaccinex, Inc.

Fundamentals / CIK 0001205922 / USD

Vaccinex, Inc. reported $601K in revenue and a net loss of $18.63M for the fiscal year ended December 31, 2024 (up 5.4% year over year), with a -3117.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open VCNX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2017 to 2024), reported in USD.

$4.25M$2.13M$0-$29.87MFY 2017 Revenue: $90KFY 2017 Net Income: -$18.72M2017FY 2018 Revenue: $724KFY 2018 Net Income: -$29.52M2018FY 2019 Revenue: $523KFY 2019 Net Income: -$31.86M2019FY 2020 Revenue: $625KFY 2020 Net Income: -$28.85M2020FY 2021 Revenue: $900KFY 2021 Net Income: -$22.38M2021FY 2022 Revenue: $275KFY 2022 Net Income: -$19.82M2022FY 2023 Revenue: $570KFY 2023 Net Income: -$20.25M2023FY 2024 Revenue: $601KFY 2024 Net Income: -$18.63M2024

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $601K $570K $275K $900K $625K $523K $724K $90K
Cost of Revenue -- -- -- -- $2.0K $199K $1.03M $160K
Gross Profit -- -- -- -- $623K $324K -$309K -$70K
Research & Development $12.54M $16.57M $13.98M $17.16M $21.55M $25.67M $22.35M $16.55M
Operating Income -$18.73M -$22.89M -$19.91M -$22.49M -$28.33M -$32.02M -$27.28M -$21.10M
EBITDA -$18.64M -$22.77M -$19.70M -$22.32M -$28.02M -$31.77M -$27.06M -$20.90M
Interest Expense $2.0K $1.0K $2.0K $809K $489K -- $392K $1.36M
Income Before Tax -$18.63M -$20.25M -$19.82M -$22.38M -$28.85M -$31.86M -$29.52M -$18.76M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$18.63M -$20.25M -$19.82M -$22.38M -$28.85M -$31.86M -$29.52M -$18.72M
Basic EPS -$8.88 -$43.68 -$9,808.92 -$1,625,650.26 -$3,209,617.18 -$5,147,892.49 -$11,775,543.55 -$41,474,923.30
Diluted EPS -$8.88 -$43.68 -$9,808.92 -$1,625,650.26 -$3,209,617.18 -$5,147,892.49 -$11,775,543.55 -$41,474,923.30
Basic Shares Outstanding 2.1M 463.7K 2.0K 14 9 6 3 1
Diluted Shares Outstanding 2.1M 463.7K 2.0K 14 9 6 3 1

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Revenue $213K $52K $232K $104K $0 $20K $0 $550K
Research & Development $2.13M $3.17M $3.86M $3.38M $3.36M $4.36M $5.05M $3.81M
Operating Income -$3.39M -$4.55M -$5.72M -$5.07M -$4.99M -$5.83M -$7.08M -$4.99M
EBITDA -$3.37M -$4.53M -$5.70M -$5.05M -$4.96M -$5.80M -$7.05M -$4.96M
Interest Expense -- -- -- -- $2.0K $0 $0 $0
Income Before Tax -$3.37M -$5.73M -$5.63M -$3.90M -$3.32M -$4.91M -$7.06M -$4.96M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$3.37M -$5.73M -$5.63M -$3.90M -$3.32M -$4.91M -$7.06M -$4.96M
Basic EPS -- -$2.83 -$43.42 -$41.18 -- -$15.25 -$343.70 -$292.58
Diluted EPS -- -$2.83 -$43.42 -$41.18 -- -$15.25 -$343.70 -$292.58
Basic Shares Outstanding -- 2.0M 129.8K 94.8K -- 322.2K 20.5K 17.0K
Diluted Shares Outstanding -- 2.0M 129.8K 94.8K -- 322.2K 20.5K 17.0K

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $1.11M $1.53M $6.39M $8.59M $10.60M $2.78M $5.62M $4.18M
Short-Term Investments -- -- -- -- -- $0 $14.11M --
Cash & Short-Term Investments $1.11M $1.53M $6.39M $8.59M $10.60M $2.78M $19.72M $4.18M
Accounts Receivable, Net $838K $961K $175K -- $157K $898K $639K $117K
Total Current Assets $2.53M $3.35M $7.48M $9.40M $11.29M $4.01M $21.42M $4.97M
Property, Plant & Equipment, Net $65K $136K $189K $297K $416K $594K $604K $601K
Total Non-Current Assets $65K $282K $499K $438K $416K $594K $604K $601K
Total Assets $2.60M $3.63M $7.98M $9.84M $11.70M $4.60M $22.03M $5.58M
Accounts Payable $3.96M $2.04M $1.52M $1.06M $3.17M $3.21M $2.32M $1.91M
Short-Term Debt $25K $75K $74K $74K -- -- -- --
Deferred Revenue (Current) $0 $63K -- -- -- -- -- $298K
Total Current Liabilities $5.08M $5.92M $2.54M $2.26M $13.18M $6.88M $6.69M $4.17M
Long-Term Debt $0 $26K $101K $175K $1.13M -- -- --
Total Non-Current Liabilities $0 $26K $247K $175K $1.13M $0 $0 $3.18M
Total Liabilities $5.08M $5.94M $2.78M $2.43M $14.31M $6.88M $6.69M $7.35M
Total Debt (incl. Leases) $25K $247K $485K $390K $1.13M -- -- --
Common Stock $1.0K $0 $0 $3.0K $3.0K $1.0K $1.0K --
Retained Earnings -$358.6M -$339.9M -$319.7M -$299.9M -$277.5M -$248.6M -$216.8M -$187.2M
Total Stockholders' Equity -- -- -- $7.41M -$26.57M -$26.24M -$8.62M -$125.5M
Total Equity -$2.49M -$2.31M $5.19M $7.41M -$2.61M -$2.27M $15.34M -$113.5M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Cash & Cash Equivalents $1.11M $2.91M $233K $2.97M $1.53M $127K $1.91M $3.32M
Cash & Short-Term Investments $1.11M $2.91M $233K $2.97M $1.53M $127K $1.91M $3.32M
Accounts Receivable, Net $838K $985K $1.04M $2.77M $961K $933K $11K --
Total Current Assets $2.53M $4.76M $2.20M $7.15M $3.35M $2.21M $2.68M $4.42M
Property, Plant & Equipment, Net $65K $82K $106K $110K $136K $164K $177K $207K
Total Non-Current Assets $65K $97K $165K $213K $282K $352K $406K $477K
Total Assets $2.60M $4.85M $2.37M $7.37M $3.63M $2.56M $3.08M $4.89M
Accounts Payable $3.96M $4.87M $3.24M $2.33M $2.04M $4.22M $1.61M $1.09M
Short-Term Debt $25K $44K $63K $76K $75K $75K $75K $75K
Deferred Revenue (Current) $0 $51K $12K $59K $63K -- -- --
Total Current Liabilities $5.08M $6.17M $5.23M $4.71M $5.92M $6.36M $3.38M $2.31M
Long-Term Debt $0 -- -- $6.0K $26K $44K $63K $82K
Total Non-Current Liabilities $0 $0 $0 $6.0K $26K $65K $125K $185K
Total Liabilities $5.08M $6.17M $5.23M $4.71M $5.94M $6.43M $3.51M $2.50M
Total Debt (incl. Leases) $25K $59K $122K $185K $247K $307K $367K $427K
Common Stock $1.0K $1.0K $1.0K $1.0K $0 $0 $7.0K $5.0K
Retained Earnings -$358.6M -$355.2M -$349.5M -$343.8M -$339.9M -$336.6M -$331.7M -$324.6M
Total Equity -$2.49M -$1.32M -$2.86M $2.65M -$2.31M -$3.87M -$423K $2.40M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$18.63M -$20.25M -$19.82M -$22.38M -$28.85M -$31.86M -$29.52M -$18.76M
Depreciation & Amortization $94K $119K $207K $169K $307K $249K $223K $206K
Stock-Based Compensation $341K $474K $545K $541K $732K $447K $177K $319K
Change in Receivables $123K -$786K -$175K $157K $741K -$260K -$522K -$13K
Change in Payables $1.91M $521K $457K -$2.11M $122K $725K $421K -$555K
Operating Cash Flow -$16.19M -$21.38M -$19.07M -$25.30M -$28.65M -$30.71M -$25.28M -$21.39M
Capital Expenditure -$22K -$67K -$99K -$32K -$290K -$78K -$235K -$68K
Free Cash Flow -$16.21M -$21.45M -$19.17M -$25.33M -$28.94M -$30.79M -$25.51M -$21.45M
Purchases of Investments -- -- -- -- -- -- -$20.76M --
Investing Cash Flow -$22K -$67K -$99K -$32K -$290K $14.07M -$14.24M -$68K
Common Stock Issued -- $1.28M $3.56M $32.85M $17.00M -- -- --
Financing Cash Flow $15.78M $16.59M $16.98M $23.32M $36.76M $13.80M $40.95M $23.97M
Net Change in Cash -$428K -$4.86M -$2.20M -$2.01M $7.82M -$2.84M $1.44M $2.52M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Net Income -$3.37M -$5.73M -$5.63M -$3.90M -$3.32M -$4.91M -$7.06M -$4.96M
Depreciation & Amortization $17K $24K $25K $27K $26K $31K $30K $31K
Stock-Based Compensation $57K $76K $112K $96K $104K $115K $126K $129K
Change in Receivables $147K $60K -$20K -$64K -$28K -$922K -$11K $175K
Change in Payables -$912K $1.63M $906K $290K -$2.19M $2.62M $515K -$425K
Operating Cash Flow -$3.93M -$3.21M -$4.42M -$4.63M -$7.74M -$3.10M -$5.51M -$5.04M
Capital Expenditure $0 -$8.0K -$14K $0 $0 -$18K $0 -$49K
Free Cash Flow -$3.93M -$3.21M -$4.43M -$4.63M -$7.74M -$3.11M -$5.51M -$5.09M
Investing Cash Flow $0 -$8.0K -$14K $0 $0 -$18K $0 -$49K
Financing Cash Flow $2.13M $5.89M $1.69M $6.07M $9.14M $1.33M $4.09M $2.02M
Net Change in Cash -$1.80M $2.67M -$2.74M $1.44M $1.41M -$1.78M -$1.42M -$3.07M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- 99.7% 62.0% -42.7% -77.8%
Operating Margin -3117.3% -4014.9% -7238.5% -2498.9% -4533.0% -6121.4% -3768.1% -23448.9%
Net Profit Margin -3100.5% -3552.8% -7205.5% -2486.7% -4616.2% -6092.4% -4077.1% -20802.2%
Return on Equity (ROE) -- -- -- -301.9% -- -- -- --
Return on Assets (ROA) -717.8% -557.7% -248.4% -227.4% -246.5% -692.1% -134.0% -335.8%
Current Ratio 0.50x 0.57x 2.95x 4.17x 0.86x 0.58x 3.20x 1.19x
Quick Ratio 0.38x 0.42x 2.59x 3.81x 0.82x 0.53x 3.05x 1.03x
Debt to Equity -- -- -- 0.05x -- -- -- --
Revenue Growth (YoY) +5.4% +107.3% -69.4% +44.0% +19.5% -27.8% +704.4% --
Gross Profit Growth (YoY) -- -- -- -- +92.3% -- -- --
5Y Revenue / Share Growth -100.0% -100.0% -99.8% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Operating Margin -3117.3% -5241.2% -6072.5% -18526.6% -4014.9% -- -- --
Net Profit Margin -3100.5% -4787.9% -4987.9% -15472.6% -3552.8% -- -- --
Return on Assets (ROA) -717.8% -382.7% -750.2% -260.4% -557.7% -860.5% -708.6% -412.3%
Current Ratio 0.50x 0.77x 0.42x 1.52x 0.57x 0.35x 0.79x 1.91x
Quick Ratio 0.38x 0.63x 0.24x 1.22x 0.42x 0.17x 0.57x 1.44x
Revenue Growth (YoY) -- +160.0% -- -81.1% -- -60.0% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001205922) · from June 30, 2017 Data through December 31, 2024 · synced Nov 21, 2026, 05:11 UTC · Open in terminal